PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

TERUMO ANNOUNCES GLOBAL COMMERCIAL LAUNCH OF K-PACK EMBRACE™ ACTIVE SAFETY NEEDLE

Terumo Corporation (TSE: 4543) today announced the global commercial launch of its K-Pack Embrace™ active safety needle. The new safety injection needle is packaged in a rigid cap and case container, designed to facilitate the downstream co-packing processes and protect the needle through the product life cycle until the point of use.  

Co-packing a pre-selected injection needle with a drug product and syringe can significantly reduce the risks to the patient, add convenience for the healthcare professional (HCP) and simultaneously maintain the value proposition of the product for the drug company. Automated co-packing processes require enhanced hard-shell protection of needles for easy handling during co-packing and to maintain needle sterility and performance over the product’s intended shelf life.

The K-Pack Embrace™ active safety needle is designed specifically for automated co-packing processes with its compact hard-shell case. It is intended for subcutaneous (SC), intramuscular (IM) and intravenous (IV) applications and includes Terumo’s T-Sharp™ technology with integrated needle shield safety features. Available in either 1” (25mm) or 5/8” (16mm) lengths, the K-Pack Embrace™ 25-gauge needle is compatible with all ISO 80369-7 male connectors and its color-coded, tamper-evident label includes a 2D barcode (UDI carrier) that supports automated in-line visual inspection. 
K-Pack Embrace™ reduces the risk of needle stick injuries with its integrated hinged needle shield, which can be activated with one hand and provides audible, visual and tactile confirmation of engagement.  

“The K-Pack Embrace™ active safety needle is a great example of applying our Deviceutical™ approach that brings devices and pharmaceuticals together for uniquely integrated injectable drug delivery solutions,” said Nicolas Eon, Global Product Manager, Injection and Infusion Platforms, Pharmaceutical Solutions Division, Terumo.  
“The K-Pack Embrace™ design simultaneously protects the healthcare professional, patient and product, all while making the efficiencies of automated co-packing available to our pharmaceutical customers,” continues Marco Chiado Piat, President, Pharmaceutical Solutions Division, Terumo. “This new active safety needle builds protection and safety into a single product that aligns with our goal of producing injectable drug delivery solutions that improve the lives of patients.”

CaptionK-Pack Embrace™ Active Safety Needle

 

 For more information about the K-Pack Embrace™ active safety needle, visithttps://www.terumopharmaceuticalsolutions.com/en/k-pack-embrace-active-safety-needle

About Terumo Pharmaceutical Solutions Division

Pharmaceutical Solutions Division (PSD) aspires to be the preferred partner of pharma customers for innovative medical devices and injectable drug delivery solutions, providing safe and effective products that improve people’s lives. Our integrated Contract Development and Manufacturing Organization (CDMO) services include the sterile fill finish of injectable drug products in polymer prefillable syringes (PFS) and glass vials.

Our range of high-quality needles, syringes, infusion sets, and primary packaging prefillable syringes (PFS) can support the requirements of many pharmaceutical and biotechnology companies located around the globe.
www.terumopharmaceuticalsolutions.com

About Terumo

Terumo (TSE: 4543) is a global medical innovation company. Guided by an unwavering commitment to patients, and driven by the passion of our associates, we strive to fulfill our Group Mission of “Contributing to Society through Healthcare.” Founded in Tokyo in 1921, we provide a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026